As the world prepares for a “diabetes tsunami,” eye care experts believe AI could be key to saving health systems money.

A retinal scan of a young mouse genetically predisposed to diabetes and obesity. Over time, the retina undergoes changes consistent with diabetic retinopathy, a condition where blood vessels swell or ...

Vision changes are an inevitable part of aging, but why are some more susceptible to age-related eye diseases and why do some ...

Ocular biomarkers for anemia in diabetic kidney disease include disruption of the external limiting membrane and ellipsoid zone.

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic macular edema (DME) who have previously responded to at least 2 ...

In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...

Alvotech (ALVO) and Teva Pharmaceuticals (TEVA) announced that the FDA has accepted for review a Biologics License Application, or BLA, for ...

The Government of Kerala, in collaboration with Remidio, a leader in AI-driven ophthalmic screening solutions, has launched ...

Cataracts, dry eyes, glaucoma and other eye problems become more common with age. But these can be treated — and sometimes ...

Diabetic retinopathy is a severe complication of diabetes that can lead to blindness. The Japanese clinical practice ...

The DVLA must be notified of any condition that affects both eyes or the single eye if you only have vision in one. Failing ...